➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson
Boehringer Ingelheim
Express Scripts

Last Updated: July 13, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Filibuvir

Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

What is the drug development status for Filibuvir?

Filibuvir is an investigational drug.

There have been 4 clinical trials for Filibuvir. The most recent clinical trial was a Phase 2 trial, which was initiated on November 1st 2009.

The most common disease conditions in clinical trials are Hepatitis C, Hepatitis, Chronic, and Hepatitis C, Chronic. The leading clinical trial sponsors are Pfizer and [disabled in preview].

Recent Clinical Trials for Filibuvir
Drug Interaction Study Of Filibuvir With Methadone Among Subjects On Chronic Methadone MaintenancePfizerPhase 1
Investigation Of The Effect Of Steady State Filibuvir On The Pharmacokinetics Of Oral Contraceptives (Levonorgestrel And Ethinyl Estradiol)PfizerPhase 1
A Study To Investigate Safety And Pharmacokinetics Of A Single Dose Of PF-00868554 (Filibuvir) In Japanese Healthy Adult VolunteersPfizerPhase 1

See all Filibuvir clinical trials

Clinical Trial Summary for Filibuvir

Top disease conditions for Filibuvir
Top clinical trial sponsors for Filibuvir

See all Filibuvir clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.